John Trizzino, EVP, CCO and CBO at NOVAVAX INC (NVAX), sold 29,888 shares at $223.95 ($6.8M) on 2021-09-21, disclosed to the SEC on 2021-09-22.
Open-market sale of $6.8M NVAX by EVP, CCO and CBO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $223.18 | 662 | $148K | 2.2% |
| 2 | $223.18 | 662 | $148K | 2.2% |
| 3 | $224.77 | 705 | $158K | 2.3% |
| 4 | $224.77 | 705 | $158K | 2.3% |
| 5 | $225.68 | 1,032 | $233K | 3.4% |
| 6 | $225.68 | 1,032 |
| $233K |
| 3.4% |
| 7 | $226.65 | 1,175 | $266K | 3.9% |
| 8 | $226.65 | 1,175 | $266K | 3.9% |
| 9 | $227.87 | 578 | $132K | 1.9% |
| 10 | $227.87 | 578 | $132K | 1.9% |
| 11 | $228.72 | 1,307 | $299K | 4.4% |
| 12 | $228.72 | 1,307 | $299K | 4.4% |
| 13 | $229.92 | 918 | $211K | 3.1% |
| 14 | $229.92 | 918 | $211K | 3.1% |
| 15 | $230.69 | 755 | $174K | 2.6% |
| 16 | $230.69 | 755 | $174K | 2.6% |
| 17 | $231.90 | 256 | $59K | 0.9% |
| 18 | $231.90 | 256 | $59K | 0.9% |
| 19 | $232.90 | 112 | $26K | 0.4% |
| 20 | $223.95 | 819 | $183K | 2.7% |
| 21 | $223.95 | 819 | $183K | 2.7% |
| 22 | $224.79 | 1,269 | $285K | 4.2% |
| 23 | $224.79 | 1,269 | $285K | 4.2% |
| 24 | $226.24 | 1,365 | $309K | 4.5% |
| 25 | $226.24 | 1,365 | $309K | 4.5% |
| 26 | $227.09 | 585 | $133K | 2.0% |
| 27 | $227.09 | 585 | $133K | 2.0% |
| 28 | $228.22 | 853 | $195K | 2.9% |
| 29 | $228.22 | 853 | $195K | 2.9% |
| 30 | $229.03 | 726 | $166K | 2.4% |
| 31 | $229.03 | 726 | $166K | 2.4% |
| 32 | $230.31 | 1,515 | $349K | 5.1% |
| 33 | $230.31 | 1,515 | $349K | 5.1% |
| 34 | $231.11 | 368 | $85K | 1.3% |
| 35 | $231.11 | 368 | $85K | 1.3% |
| Total | $227.45 avg | 29,888 | $6.8M | 100% |
| Filing → |
| NVAX | SELL | 2021-09-15 | $7.0M | — | Filing → |
| NVAX | SELL | 2021-05-07 | $802K | — | Filing → |
| NVAX | SELL | 2021-04-07 | $1.2M | — | Filing → |